🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea flag South Korea · Delayed Price · Currency is KRW
77,300
-5,100 (-6.19%)
Nov 20, 2026, 3:30 PM KST

OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 2.62B KRW in the quarter ending June 30, 2026, a decrease of -58.02%. This brings the company's total for the last twelve months to 13.64B, up 80.93% year-over-year. In the year 2025, OliX Pharmaceuticals had annual revenue of 14.67B with 158.35% growth. That makes OliX Pharmaceuticals the 37,356th largest company in the world by revenue and 2,381st in South Korea.

Revenue (ttm)
13.64B
Revenue Growth
+80.93%
P/S Ratio
128.97
Revenue / Employee
168.35M
Employees
81
Market Cap
1.76T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.67B8.99B158.35%
Dec 31, 20245.68B-11.39B-66.73%
Dec 31, 202317.06B7.74B83.09%
Dec 31, 20229.32B5.65B153.66%
Dec 31, 20213.67B1.20B48.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Chabiotech1.31T
SK bioscience690.95B
Hugel471.19B
HLB Co., Ltd.101.34B
LigaChem Biosciences71.90B
ABL Bio34.28B
Peptron6.00B
Kolon TissueGene4.80B
Revenue Rankings